| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.09 |